Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,698,308
  • Shares Outstanding, K 49,215
  • Annual Sales, $ 4,050 M
  • Annual Income, $ 22,200 K
  • EBIT $ 555 M
  • EBITDA $ 1,132 M
  • 60-Month Beta 1.63
  • Price/Sales 2.39
  • Price/Cash Flow 9.08
  • Price/Book 2.84

Options Overview Details

View History
  • Implied Volatility 37.99% (-0.36%)
  • Historical Volatility 31.83%
  • IV Percentile 18%
  • IV Rank 10.67%
  • IV High 86.39% on 04/11/25
  • IV Low 32.21% on 06/18/25
  • Expected Move (DTE 26) 21.63 (10.98%)
  • Put/Call Vol Ratio 0.45
  • Today's Volume 1,145
  • Volume Avg (30-Day) 461
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 5,796
  • Open Int (30-Day) 4,590
  • Expected Range 175.43 to 218.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.33
  • Number of Estimates 7
  • High Estimate 2.36
  • Low Estimate 2.31
  • Prior Year 2.66
  • Growth Rate Est. (year over year) -12.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.49 +25.13%
on 11/21/25
200.58 -1.75%
on 12/15/25
+35.42 (+21.91%)
since 11/19/25
3-Month
144.26 +36.60%
on 09/25/25
200.58 -1.75%
on 12/15/25
+41.67 (+26.82%)
since 09/19/25
52-Week
91.86 +114.52%
on 04/11/25
200.58 -1.75%
on 12/15/25
+14.91 (+8.19%)
since 12/19/24

Most Recent Stories

More News
Is Charles River Laboratories Stock Underperforming the Dow?

Despite lagging the Dow Jones Industrial Average over the past year, Charles River Laboratories continues to attract cautious optimism from analysts regarding its longer-term outlook.

JPM : 317.21 (+1.35%)
$DOWI : 48,134.89 (+0.38%)
CRL : 197.06 (+1.66%)
LH : 252.03 (unch)
Stocks Fall Ahead of US November Payroll Report

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down by -0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.51%....

MSTR : 164.82 (+4.16%)
IMNM : 21.44 (+7.47%)
GLXY : 24.00 (+6.62%)
BLDR : 103.79 (-1.73%)
$IUXX : 25,346.18 (+1.31%)
COIN : 245.12 (+2.47%)
ZNH26 : 112-160s (-0.22%)
OXY : 39.62 (-0.28%)
ESH26 : 6,887.25s (+0.83%)
FANG : 148.13 (+0.77%)
LYB : 43.09 (+0.07%)
$DOWI : 48,134.89 (+0.38%)
Stocks Turn Lower on AI Spending Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.26%. December E-mini...

MSTR : 164.82 (+4.16%)
AMAT : 256.41 (+1.15%)
IMNM : 21.44 (+7.47%)
GLXY : 24.00 (+6.62%)
BLDR : 103.79 (-1.73%)
AKAM : 89.22 (+0.82%)
$IUXX : 25,346.18 (+1.31%)
COIN : 245.12 (+2.47%)
ZNH26 : 112-160s (-0.22%)
OXY : 39.62 (-0.28%)
ESH26 : 6,887.25s (+0.83%)
FANG : 148.13 (+0.77%)
Stocks Climb in Anticipation of Fed-Friendly US Economic News

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.50%. December E-mini S&P futures...

TER : 195.18 (+2.48%)
AMAT : 256.41 (+1.15%)
IMNM : 21.44 (+7.47%)
B : 44.73 (+1.96%)
HL : 19.67 (+3.36%)
AKAM : 89.22 (+0.82%)
TXN : 176.29 (+0.06%)
$IUXX : 25,346.18 (+1.31%)
ASML : 1,056.02 (+1.90%)
ZNH26 : 112-160s (-0.22%)
ESH26 : 6,887.25s (+0.83%)
LYB : 43.09 (+0.07%)
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

Final 2025 global cohort onboarding, with applications now open for 2026

CRL : 197.06 (+1.66%)
1 Profitable Stock with Exciting Potential and 2 We Avoid

1 Profitable Stock with Exciting Potential and 2 We Avoid

PKOH : 22.55 (-1.74%)
CRL : 197.06 (+1.66%)
EEFT : 77.02 (+0.13%)
Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know

Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know

CRL : 197.06 (+1.66%)
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

CRL : 197.06 (+1.66%)
Charles River Laboratories to Present at Evercore Healthcare Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Evercore 8 th Annual Healthcare Conference on Wednesday, December 3 rd ...

CRL : 197.06 (+1.66%)
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC (“KSF”), announces that KSF has commenced an investigation into...

CRL : 197.06 (+1.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 206.08
2nd Resistance Point 202.21
1st Resistance Point 199.63
Last Price 197.06
1st Support Level 193.19
2nd Support Level 189.32
3rd Support Level 186.74

See More

52-Week High 200.58
Last Price 197.06
Fibonacci 61.8% 159.05
Fibonacci 50% 146.22
Fibonacci 38.2% 133.39
52-Week Low 91.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar